Patent Application
20060229819
The present invention relates in general to molecular biological systems and more particularly to a means to simplify the detection process for colored bead random microarrays.
Ever since their invention in the early 1990s (Science, 251, 767-773, 1991), high-density arrays formed by the spatially addressable synthesis of bioactive probes on a 2-dimensional solid support have greatly enhanced and simplified the process of biological research and development. The key to current microarray technology is deposition of a bioactive agent at a single spot on a microchip in a “spatially addressable” manner.
Current technologies have used various approaches to fabricate microarrays. For example, U.S. Pat. No. 5,412,087, inv. McGall et al., issued on May 2, 1995 and U.S. Pat. No. 5,489,678, inv. Fodor et al., issued Feb. 6, 1996, demonstrate the use of a photolithographic process for making peptide and DNA microarrays. The patent teaches the use of photolabile protecting groups to prepare peptide and DNA microarrays through successive cycles of deprotecting a defined spot on a 1 cm.-x 1 cm chip by photolithography, then flooding the entire surface with an activated amino acid or DNA base. Repetition of this process allows construction of a peptide or DNA microarray with thousands of arbitrarily different peptides or oligonucleotide sequences at different spots on the array. This method is expensive.
An ink jet approach is being used by others (e.g., Papen et al., U.S. Pat. No. 6,079,283, issued Jun. 27, 2000, U.S. Pat. No. 6,083,762; issued, Jul. 4, 2000 and U.S. Pat. No. 6,094,966, issued Aug. 1, 2002) to fabricate spatially addressable arrays, but this technique also suffers from high manufacturing cost in addition to the relatively large spot size of 40 to 100 μm. Because the number of bioactive probes to be placed on a single chip usually runs anywhere from 1000 to 100000 probes, the spatial addressing method is intrinsically expensive regardless how the chip is manufactured.
An alternative approach to the spatially addressable method is the concept of using fluorescent dye-incorporated polymeric beads to produce biological multiplexed arrays. U.S. Pat. No. 5,981,180, inv. Chandler et al., issued Nov. 9, 1999 discloses a method of using color coded beads in conjunction with flow cytometry to perform multiplexed biological assay. Microspheres conjugated with DNA or monoclonal antibody probes on their surfaces were dyed internally with various ratios of two distinct fluorescence dyes. Hundreds of “spectrally addressed” microspheres were allowed to react with a biological sample and the “liquid array” was analyzed by passing a single microsphere through a flow cytometry cell to decode sample information.
U.S. Pat. No. 6,023,540, inv. Walt et al., issued Feb. 8, 2000 discloses the use of fiber-optic bundles with pre-etched microwells at distal ends to assemble dye loaded microspheres. The surface of each spectrally addressed microsphere was attached with a unique bioactive agent and thousands of microspheres carrying different bioactive probes combined to form “beads array” on pre-etched microwells of fiber optical bundles.
More recently, an optically encoded microsphere approach was accomplished by using different sized zinc sulfide-capped cadmium selenide nanocrystals incorporated into microspheres (Nature Biotech. 19, 631-635, (2001)). Given the narrow band width demonstrated by these nanocrystals, this approach expands the spectral barcoding capacity in microspheres.
Even though the “spectrally addressed microsphere” approach does provide an advantage in terms of its simplicity over the old fashioned “spatially addressable” approach in microarray making, recent improvements in the art make the manufacture and use of random microarrays less difficult and less expensive.
A coating technology is described in U.S. patent application Ser. No. 2003/0170392 A1 to prepare a microarray on a substrate that need not be pre-etched with microwells or premarked in any way with sites to attract the microspheres. Using unmarked substrates, or substrates that need no pre-coating preparation, provides a manufacturing advantage compared to the existing technologies. Color addressable mixed beads in a dispersion can be randomly distributed on a receiving layer that has no wells or sites to attract the microspheres. This method provides a microarray having a substrate does not have to be modified even though the microspheres remain immobilized on the substrate, where the bead surfaces are exposed to facilitate easier access of the analyte to probes attached to the surfaces of the beads.
U.S. patent application. Ser. No. 2003/0068609 A1 discloses a coating composition and technology for making a microarray on a substrate that does not have specific sites capable of interacting physically or chemically with the microspheres. The substrate need not be pre-etched with microwells or premarked in any way with sites to attract the microspheres. Upon coating the composition on a substrate, the microspheres become immobilized in the plane of coating and form a random pattern on the substrate. Using unmarked substrates or substrates that need no pre-coating preparation provides a manufacturing means that is less costly and easier to prepare than those previously disclosed because the substrate does not have to be modified compared to the existing technologies. A composition allows color addressable mixed beads to be randomly distributed on a substrate that has no wells or sites to attract the microspheres.
A method of making a random array of microspheres using enzyme digestion to expose surfaces of the microspheres is taught in U.S. patent application Ser. No. 2003/0224361 A1. Enzyme digestion can be easily controlled to expose the desired amount of microsphere and the enzyme, a protease, is readily available and economical to obtain.
A method of manufacturing and detecting colored microarrays is described in U.S. 2004/0106114 A1. During the manufacture of the microspheres, an optical bar code is generated of the colorants associated with the microspheres and stored in a digital file. The biologically/chemically active region of a support treated with the microspheres is scanned with a high-resolution color scanner to produce a color map of the locations of the randomly dispersed set of one color of microspheres. A digital file of the color map produced is linked the digital file of the color map with the support. After the microarray is exposed to an analyte, the microarray is scanned by a monochrome scanner and a bead map of the microbeads is produced. The map is linked through the digital file to the location of the colored beads when the support was manufactured.
There is still a need in the art for improved methods of detection which will make the manufacture and use of microarrays less difficult and less expensive.
A random or ordered array of colored beads, preferably arrayed on a substrate, is imaged using a wavelength tunable light source and an imaging device, such as a digital camera. The beads are treated to act as probes, which can attach to various materials, such as proteins or genetic material, in a biological sample. More than one color of bead is present, with beads of different colors treated to probe for different materials, such as proteins or genetic material. Beads are also treated with fluorescent and/or chemiluminescent markers to indicate the presence and/or quantity of the protein or genetic material. For chemiluminescent markers, the beads are imaged during the interaction of the bead with the sample material, detecting the spatial position of the chemiluminescing beads. For fluorescent markers, the tunable light source is tuned to wavelengths that stimulate fluorescence, and an image of the beads is taken through a filter that blocks the stimulating wavelength but transmits the fluorescent emitted wavelengths. Either before or after measuring the chemiluminescence or fluorescence, the tunable light source is tuned to several wavelengths, or wavelength ranges, and the digital camera captures an image of the beads, usually with the fluorescent filter removed, at each wavelength. The spectral reflectance of each bead, which is termed the “color” of the bead, is determined by imaging the beads at several wavelengths.
The presence of protein/genetic material at probes containing fluorescent/chemiluminescent signal is indicated by the spatial position of the chemiluminescent/fluorescent signal. The spectrally determined “color” of the bead identifies the type of protein/genetic material for which the bead was prepared to probe, and thus the type of protein/genetic material that has been detected. There are several advantages to use of this invention. A wavelength tunable light source allows imaging of the colored beads at many different wavelengths, allowing for a more detailed spectral characterization of the beads. This results in improved identification of a bead and an improved ability to distinguish one color of bead from another. This improves the use of random arrays of beads, which are less expensive to manufacture than carefully ordered arrays. Use of non-visible wavelengths (infrared and ultraviolet) of light from the tunable light source allows for a more detailed characterization of beads than may be available from a conventional color camera. The use of wavelength tunable light allows imaging of the microarray with light tuned to a wavelength that stimulates a particular fluorescent molecule, and additional imaging when the light is tuned to a different wavelength which stimulates a different fluorescent molecule.
The foregoing and other objects, features, and advantages of the invention will be apparent from the following more particular description of the embodiments of the invention, as illustrated in the accompanying drawings. The elements of the drawings are not necessarily to scale relative to each other.
The following is a detailed description of the preferred embodiments of the invention, reference being made to the drawings in which the same reference numerals identify the same elements of structure in each of the several figures.
The present invention teaches a method for imaging a random or ordered array of microspheres, also referred to as “beads”, immobilized in a coating on a substrate. The microspheres are desirably formed to have a mean diameter in the range of 1 to 50 microns; more preferably in the range of 3 to 30 microns and most preferably in the range of 5 to 20 microns. It is preferred that the concentration of microspheres in the coating is in the range of 100 to a million per cm2, more preferably 1000 to 200,000 per cm2 and most preferably 10,000 to 100,000 per cm2.
Although microspheres or particles having a substantially curvilinear shape are preferred because of ease of preparation, particles of other shape such as ellipsoidal or cubic particles may also be employed. Suitable methods for preparing the particles are emulsion polymerization as described in “Emulsion Polymerization” by I. Piirma, Academic Press, New York (1982) or by limited coalescence as described by T. H. Whitesides and D. S. Ross in J. Colloid Interface Science, vol. 169, pages 48-59, (1985). The particular polymer employed to make the particles or microspheres is a water immiscible synthetic polymer that may be colored. The preferred polymer is any amorphous water immiscible polymer. Examples of polymer types that are useful are polystyrene, poly(methyl methacrylate) or poly(butyl acrylate). Copolymers such as a copolymer of styrene and butyl acrylate may also be used. Polystyrene polymers are conveniently used.
The beads are treated to act as “probes”, by the attachment of bioactive agents to the surface of chemically functionalized microspheres. This can be performed according to the published procedures in the art (Bangs Laboratories, Inc, Technote #205). Some commonly used chemical functional groups include, but are not limited to, carboxyl, amino, hydroxyl, hydrazide, amide, chloromethyl, epoxy, aldehyde, etc. Examples of bioactive agents or probes include, but are not limited to, oligonucleotides, DNA and DNA fragments, PNAs, peptides, antibodies, enzymes, proteins, and synthetic molecules having biological activities.
The beads are also treated with a colorant, or combination of colorants, which allows for the detection of beads based on their color. The formed microsphere is colored using an insoluble colorant that is a pigment or dye that is not dissolved during array coating or subsequent treatment. Suitable dyes may be oil-soluble in nature. It is preferred that the dyes are non-fluorescent when incorporated in the microspheres. Methods for coating beads are broadly described by Edward Cohen and Edgar B. Gutoff in Chapter 1 of “Modern Coating And Drying Technology”, (Interfacial Engineering Series; v.1), (1992), VCH Publishers Inc., New York, N.Y. For a single layer format, suitable coating methods may include dip coating, rod coating, knife coating, blade coating, air knife coating, gravure coating, forward and reverse roll coating, and slot and extrusion coating. Beads are also treated with fluorescent and/or chemiluminescent markers to indicate the presence and/or quantity of the protein or genetic material. The location of the fluorescent and/or chemiluminescent markers are matched with the location of the colored beads to identify the probes that interacted with the biological material.
The microarray consists of two or more types of beads, each of which is treated to react with a specific moiety and has a unique color. The distribution or pattern of the microspheres on the substrate is either arrayed or entirely random. The microspheres are not attracted or held to sites that are pre-marked or predetermined on the substrate. The term “random distribution”, as used herein, means a spatial distribution of elements showing no preference or bias. Randomness can be measured in terms of compliance with that which is expected by a Poisson distribution. The surface of the microspheres bear capture agents, or probes, which are readily accessible to analytes with which they come in contact.
During, or after, exposure to a biological sample, a random or ordered array of colored beads, preferably arrayed on a substrate, is imaged by illuminating the microarray using a wavelength tunable light source 10 and an imaging device 15, such as a color camera as illustrated in
The presence of biological material at probes containing a fluorescent/chemiluminescent signal is indicated by the spatial position of the chemiluminescent/fluorescent signal. The spectrally determined “color” of the bead at the location of the chemiluminescent/fluorescent signal identifies the bead and the corresponding moiety for which the bead was prepared to probe.
The invention has been described in detail with particular reference to certain preferred embodiments thereof, but it will be understood that variations and modifications can be effected within the spirit and scope of the invention.
All documents, patents, journal articles and other materials cited in the present application are hereby incorporated by reference.
The invention has been described in detail with particular reference to a presently preferred embodiment, but it will be understood that variations and modifications can be effected within the spirit and scope of the invention. The presently disclosed embodiments are therefore considered in all respects to be illustrative and not restrictive. The scope of the invention is indicated by the appended claims, and all changes that come within the meaning and range of equivalents thereof are intended to be embraced therein.
